SOPHiA GENETICS (SOPH) Non-Current Debt (2020 - 2026)
SOPHiA GENETICS (SOPH) posted Non-Current Debt of $47.7 million for Q4 2025, little changed sequentially from $47.6 million in Q3 2025, and up 260.6% YoY from $13.2 million in Q4 2024.
SOPHiA GENETICS (SOPH) Non-Current Debt (2020 - 2026) Analysis & Trends
SOPHiA GENETICS has reported Non-Current Debt for 3 years, with the latest figure at $47.7 million in Q4 2025.
- Quarterly Non-Current Debt rose 260.6% year-over-year to $47.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $47.7 million (up 260.6% YoY) and the FY2025 annual result came in at $47.7 million, up 260.6% from the prior year.
- Non-Current Debt held at $47.7 million in Q4 2025 per SOPH's latest filing, from $47.6 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $47.7 million in Q4 2025 and troughed at $13.2 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 2.15 Bn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 942.66 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | - |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | - |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 1.45 Bn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | - |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | SOPHiA GENETICS | 553.79 Mn | 446.12 Mn | - | 48.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.00 Mn |
| Dec 31, 2025 | 47.73 Mn |
| Sep 30, 2025 | 47.58 Mn |
| Jun 30, 2025 | 47.47 Mn |
| Mar 31, 2025 | 13.32 Mn |
| Dec 31, 2024 | 13.24 Mn |
| Sep 30, 2024 | 13.16 Mn |
| Jun 30, 2024 | 13.34 Mn |
| Dec 31, 2020 | 457,000.00 |